CTG-16

N/A

Report date: 2024/07/15 11:17:48
NME

Base Information

Drug NameCTG-16
Drug Alias NameCTG16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 activators
TargetsNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou X-cutag Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou X-cutag Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A